metformin and semaglutide together for weight loss + Semaglutide: Safety, Benefits & Dosing Semaglutide Plus Low-Dose Metformin Combination
Description
The approval was backed by the Phase II open-label AGAVE-201 trial, where treatment with a 0.3-mg/kg dose of Niktimvo elicited an overall response rate of 75%, with a median time to response of 1.5 months

Most practitioners check B12 levels at 3-6 months after initiating tirzepatide and then every 6-12 months during maintenance
The blank days are deliberate there is no daily dosing here
For weight management, NICE has published technology appraisals for specific GLP-1 agents (semaglutide/Wegovy and liraglutide/Saxenda)

JAMA 2016;316:500508

Important Regulatory Reminders: Dietary supplements are not FDA-approved for treating medical conditions